NT5E and glioblastoma: The inhibition of CD73 activity and the pharmacological blockade of ARs decreased cell adhesion to the extracellular matrix of U138MG glioblastoma cells, demonstrating the pivotal role played by extracellular adenosine in controlling aggressive traits of GBM [37,38].